-
Feb 15, 2022, 3:10 pm228 pts
Mugglehead
Medical cannabinoid developer Brains Bioceutical Corp. is starting a clinical trial in New York looking at the effect of pharmaceutical-grade CBD as treatment for opioid-use issues. Last week, the Vancouver-headquartered firm, with operations in the United Kingdom, said the study will use Brains Bio’s EU-GMP…
Trending Today on NewsBudz
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.
